Enhanced Recovery After Cardiac Surgery (ERAS)
Cardiac Surgery, Coronary Artery Disease, Aortic Valve Disease
About this trial
This is an interventional treatment trial for Cardiac Surgery focused on measuring Enhanced recovery after Surgery, ERAS, Enhanced Recovery after Cardiac Surgery, Cardiac Surgery, Coronary Artery Bypass graft, Aortic Valve Surgery, Mitral Valve Surgery, Aortic Root Surgery
Eligibility Criteria
Inclusion Criteria:
- Having Cardiac Surgery
- Aged 18 years or older at the time of consent
- Deemed appropriate for ERAS by Surgeon and Anaesthetist
- Able and willing to provide written informed consent
Exclusion Criteria:
- Aged 18 years or under
- Deemed not suitable for ERAS by Surgeon and/or Anaesthetist
Sites / Locations
- James Cook University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
ERAS Control/non-ERAS group
ERAS group
Standard usual care after cardiac surgery.
Enhanced Recovery After Cardiac Surgery. Pre-op carbohydrate drink, Lansoprazole and Gabapentin. Intra-operative: IV Paracetamol, Dexamethasone, Ondansetron, Local Anaesthetic to wounds. Post-op: Gabapentin PO, Paracetamol IV then PO, Ondansetron IV for 24hrs. Opiate sparing. Early extubation, early mobilisation, early removal of invasive devices. Early discharge.